Finanzen von Replimune Group Inc (REPL)REPLReplimune Group Inc

Evaluating the bottom line, Replimune Group, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -134.29%, provide a clear picture of how effectively REPL converts its operational activities into shareholder value.

In the context of the broader market, REPL competes directly with industry leaders such as JANX and VOR. With a market capitalization of $1.25B, it holds a leading position in the sector. When comparing efficiency, REPL's gross margin of N/A stands against JANX's 100.00% and VOR's N/A. Such benchmarking helps identify whether Replimune Group, Inc. is trading at a premium or discount relative to its financial performance.

Replimune has been experiencing significant net losses, with a net income of -66.34 million in Q3 2025 and a forward P/E of 0, indicating no earnings expected in the near term. The company also has a high debt-to-equity ratio of 102.89% as of Q1 2027, raising concerns about financial stability.